Are you Dr. Becker?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 42 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1303 Mccullough Ave
Suite 374
San Antonio, TX 78212Phone+1 210-223-5483Fax+1 210-223-5492
Summary
- Dr. Richard Becker, MD is an endocrinologist in San Antonio, Texas. He is currently licensed to practice medicine in Texas. He is affiliated with Metropolitan Methodist Hospital and Baptist Medical Center.
Education & Training
- University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Endocrinology, Diabetes, and Metabolism, 1974 - 1975
- Yale-New Haven Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1973 - 1974
- Boston University Medical CenterResidency, Internal Medicine, 1971 - 1973
- The University of Texas Health Science Center at San AntonioClass of 1971
Certifications & Licensure
- TX State Medical License 1971 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
- Top MD Consumers Checkbook
Publications & Presentations
PubMed
- 177 citationsBiomonitoring equivalents: a screening approach for interpreting biomonitoring results from a public health risk perspectiveSean M. Hays, Richard A. Becker, Hon-Wing Leung, Lesa L. Aylward, David W. Pyatt
Regulatory Toxicology and Pharmacology. 2007-02-01 - 34 citationsThe adverse outcome pathway for rodent liver tumor promotion by sustained activation of the aryl hydrocarbon receptor.Richard A. Becker, Grace Patlewicz, Ted W. Simon, J. Craig Rowlands, Robert A. Budinsky
Regulatory Toxicology and Pharmacology. 2015-10-01 - 176 citationsIncreasing Scientific Confidence in Adverse Outcome Pathways: Application of Tailored Bradford-Hill Considerations for Evaluating Weight of Evidence.Richard A. Becker, Gerald T. Ankley, Stephen W. Edwards, Sean W. Kennedy, Igor Linkov
Regulatory Toxicology and Pharmacology. 2015-08-01